However, TIDE analysis result revealed that low GLUD1 levels correlated with higher dysfunction scores of T cells (Figure 6C), suggesting that patients with low GLUD1 levels and more immune cell infiltration tend to have a stronger signature of T cell dysfunction, which may impair the ability of cytotoxic T cells to kill cancer cells. This evidence concerns the gene GLUD1 and cancer.